ASD 소아에서 Lactobacillus Plantarum PS128의 효과
자폐스펙트럼장애아동에서 Lactobacillus Plantarum PS128의 효과
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that can cause significant social, communication and behavioral deficits. Probiotics are regarded as active microorganisms. With sufficient amounts, probiotics can regulate intestinal flora, intestinal permeability, inflammation and antioxidant reactions in the body. These reactions may further promote health, regulate metabolic disease progression and prevent complications. Lactobacillus plantarum PS128 (PS128) was reported to be a psychobiotic in several animal and human studies which modulated the levels of neurotransmitters in different brain areas. This study is to evaluate whether the consumption of PS128 can improve the symptoms of patients with ASD. The current randomized, placebo-controlled trial was conducted to investigate the psychophysiological effects of PS128 in school children with ASD.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Taoyuan, 대만
- Chang Gung Memorial Hospital
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- (1) Age 7 to 12 years old.
- (2) PS128 group and placebo group: Children with autism spectrum disorder, confirmed by Autism Diagnostic Observation Schedule.
- (3) Normal control group: Children without autism spectrum disorder.
Exclusion Criteria:
- (1) Receiving antibiotics within one month.
- (2) Probiotics used in powder, capsule, or tablet in two weeks (except for Yogurt, Yogurt, Yakult and other related foods).
- (3) Patients with hepatobiliary gastrointestinal tract who have undergone surgery (except for hernia surgery and appendectomy)
- (4) Those with special diets (gluten-free, casein-free, high-protein, and ketogenic diet).
- (5) Those with a history of cancer.
- (6) Those who are allergic to lactic acid bacteria.
- (7) Not eligible judged by PI
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: PS128
Subjects will take PS128 capsules every day (2 capsules/day, once) for 12 weeks. |
Each PS128 capsule contained >3 × 10^10 colony forming units (CFU) with microcrystalline cellulose and weights 425 ± 25 mg. |
|
위약 비교기: Placebo
Subjects will take placebo capsules every day (2 capsules/day, once) for 12 weeks. |
The placebo capsules only contained 425 ± 25 mg microcrystalline cellulose. |
|
간섭 없음: Normal control
Normal control group are enrolled by invitation from the age and gender matched healthy children. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes of Total Scores of Social Responsiveness Scale
기간: Baseline, Week 12 and Week 16
|
Social Responsiveness Scale can measure the autism clinical severity with the range from 65-260. The lower scores stand for better social responsiveness. |
Baseline, Week 12 and Week 16
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes of Total Scores of Repetitive Behavior Scale-Revised
기간: Baseline, Week 12 and Week 16
|
Repetitive Behavior Scale-Revised is a questionnaire that focuses on repetitive behavior. The score ranges from 0-129. The lower scores stand for lower repetitive behavior. |
Baseline, Week 12 and Week 16
|
|
Changes of Total Scores of Child Behavior Checklist
기간: Baseline, Week 12 and Week 16
|
Child Behavior Checklist is a parents' report questionnaire for behavioral and emotional problems. The score ranges from 0-240. The lower scores stand for better behavioral and emotional regulation. |
Baseline, Week 12 and Week 16
|
|
Changes of Total Scores of Adaptive Behavior Assessment System
기간: Baseline, week 12 and Week 16
|
Adaptive Behavior Assessment System is a parents' report questionnaire for adaptive behavior. The score ranges from 9-171. The higher scores stand for better adaptive behavior. |
Baseline, week 12 and Week 16
|
|
Changes in Accuracy of Frith-Happe Animation
기간: Baseline, Week 12 and Week 16
|
A quick and objective test of Theory of Mind. 8 questions in total, the more correct questions stand for better Social Cognition. |
Baseline, Week 12 and Week 16
|
|
Changes in Accuracy of Eyes Task
기간: Baseline, Week 12 and Week 16
|
An advanced test for Theory of Mind. 43 questions in total, the more correct questions stand for better social skills. |
Baseline, Week 12 and Week 16
|
|
Changes of Total Scores of Aberrant Behavior Checklist
기간: Baseline, Week 12 and Week 16
|
Aberrant Behavior Checklist is a parents' report questionnaire for aberrant behavior. The score ranges from 0-174. The lower scores stand for less aberrant behavior. |
Baseline, Week 12 and Week 16
|
|
Changes of Total Scores of Emotional Dysregulation Inventory
기간: Baseline, Week 12 and Week 16
|
Emotional Dysregulation Inventory is a parents' report questionnaire for emotional dysregulation. The score ranges from 0-120. The lower scores stand for better emotional regulation. |
Baseline, Week 12 and Week 16
|
|
Changes of Total Scores of Parenting Stress Index, Fourth Editon
기간: Baseline, Week 12 and Week 16
|
Parenting Stress Index is a parents' report questionnaire for parenting stress. The score ranges from 0-180. The lower scores stand for lower parenting stress. |
Baseline, Week 12 and Week 16
|
|
Assessment of Clinical Global Impression-Severity of Illness
기간: Week 12 and Week 16
|
The Clinical Global Impression (CGI) is a clinician rated measure of illness severity, improvement, and efficacy of treatment. The CGI-I is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. The score ranges from 1-7. CGI Improvement scale: 1=very much improved; 2=Much improved; 3=Minimally improved; 4=No change; 5=Minimally worse; 6=Much worse; 7=Very much worse. |
Week 12 and Week 16
|
|
Assessment of Patient Global Impression of Change
기간: Week 12 and Week 16
|
The self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment. PGIC is a 7 point scale depicting a patient's rating of overall improvement. The score ranges from 1-7. Patients rate their change as "1=very much improved ," "2=much improved," "3=minimally improved," "4=no change," "5=minimally worse," "6=much worse," or "7=very much worse)." |
Week 12 and Week 16
|
|
Gut Microbiota-Relative Abundance of Bifidobacterium Faecale
기간: Baseline and Week 12
|
Collect the DNA of fecal flora to test the diversity and abundance of gut microbiota as well as short chain fatty acids in Stool samples. The 16S rRNA gene amplicons will be prepared following the Illumina protocol for preparing the 16S metagenomic sequencing library. Values represent percentages and range from 0 to 100%, with higher values indicating a higher relative abundance of the target bacterium in the gut microbiota |
Baseline and Week 12
|
|
MRI T1
기간: Baseline and Week 12
|
Brain structural volumes (cm²). The advanced processing and analysis of the MRI data have been outsourced to an external core facility. Due to resource scheduling and the prolonged timeline required for specialized image preprocessing, the data analysis is currently in progress and has not yet been finalized. Therefore, quantifiable results are unavailable for summary in the data table at this time. |
Baseline and Week 12
|
|
Functional MRI (Resting-state/Biological Motion Task) - BOLD Signal
기간: Baseline and Week 12
|
Blood-oxygen-level-dependent (BOLD) signal is a measurement used in fMRI, which reflects the neural activity. The advanced processing and analysis of the MRI data have been outsourced to an external core facility. Due to resource scheduling and the prolonged timeline required for specialized image preprocessing, the data analysis is currently in progress and has not yet been finalized. Therefore, quantifiable results are unavailable for summary in the data table at this time. |
Baseline and Week 12
|
|
Diffusion Tensor Imaging (DTI) - FA
기간: Baseline and Week 12
|
Fractional anisotropy (FA) is a measurement used in DTI, which reflects the movement of water molecules. FA ranges from 0 to 1, the higher FA value may represent more intact axons. The advanced processing and analysis of the MRI data have been outsourced to an external core facility. Due to resource scheduling and the prolonged timeline required for specialized image preprocessing, the data analysis is currently in progress and has not yet been finalized. Therefore, quantifiable results are unavailable for summary in the data table at this time. |
Baseline and Week 12
|
|
Safety Assessment - Albumin
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as albumin (3.5-5.4 g/dl). |
Baseline and Week 12
|
|
Safety Assessment - Total Protein
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as total protein (6.4-8.3 g/dl). |
Baseline and Week 12
|
|
Safety Assessment - ALP
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as ALP (135-320 U/L). |
Baseline and Week 12
|
|
Safety Assessment - Total Bilirubin
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as total bilirubin (0.3-1.2 mg/dl). |
Baseline and Week 12
|
|
Safety Assessment - T-Cholesterol
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as T-Cholesterol (<170 mg/dL). |
Baseline and Week 12
|
|
Safety Assessment - Uric Acid
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as uric acid (<7.0 mg/dl). |
Baseline and Week 12
|
|
Safety Assessment - BUN
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as BUN (7-25 mg/dl). |
Baseline and Week 12
|
|
Safety Assessment - Creatinine
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as creatinine (0.2-1.0 mg/dl). |
Baseline and Week 12
|
|
Safety Assessment - AST
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as AST (13-40 U/L). |
Baseline and Week 12
|
|
Safety Assessment - ALT
기간: Baseline and Week 12
|
Safety is assessed function of liver and kidney such as ALT (7-40 U/L). |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Inflammatory Changes - MPO
기간: Baseline and Week 12
|
Inflammatory is assessed via a composite measure of circulating cytokines - MPO (ng/mL) |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Inflammatory Changes - IL-1β
기간: Baseline and Week 12
|
Inflammatory is assessed via a composite measure of circulating cytokines - IL-1β (pg/mL) |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Inflammatory Changes - TGF-β1
기간: Baseline and Week 12
|
Inflammatory is assessed via a composite measure of circulating cytokines - TGF-β1 (pg/mL) |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Inflammatory Changes - Eotaxin
기간: Baseline and Week 12
|
Inflammatory is assessed via a composite measure of circulating cytokines - Eotaxin (pg/mL) |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Inflammatory Changes - IL-6
기간: Baseline and Week 12
|
Inflammatory is assessed via a composite measure of circulating cytokines - IL-6 (ng/mL) |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Oxidative Stress Changes - Serotonin
기간: Baseline and Week 12
|
Oxidative stress is assessed via Serotonin (ng/mL). |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Oxidative Stress Changes - GABA
기간: Baseline and Week 12
|
Oxidative stress is assessed via GABA (μmol/L). |
Baseline and Week 12
|
|
Change in Levels of Exploratory Blood-based Biomarkers for Oxidative Stress Changes - Cortisol
기간: Baseline and Week 12
|
Oxidative stress is assessed via Cortisol (6-10am 4.82-19.5, 4-8pm 2.47-11.9, μg/dl). |
Baseline and Week 12
|
|
Gut Microbiota-Relative Abundance of Lactiplantibacillus Plantarum
기간: Baseline and Week 12
|
Collect the DNA of fecal flora to test the diversity and abundance of gut microbiota as well as short chain fatty acids in Stool samples. The 16S rRNA gene amplicons will be prepared following the Illumina protocol for preparing the 16S metagenomic sequencing library. Values represent percentages and range from 0 to 100%, with higher values indicating a higher relative abundance of the target bacterium in the gut microbiota. |
Baseline and Week 12
|
공동 작업자 및 조사자
협력자
협력자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 202101416A3
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .